Dow Up0.11% Nasdaq Up0.50%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
13.50 Up 0.29(2.20%) Aug 29, 4:00PM EDT
|After Hours : 13.60 Up 0.10 (0.74%) Aug 29, 7:51PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,466   3,458   10,567   2,389  
Cost of Revenue -   -   -   -  
Gross Profit 1,466   3,458   10,567   2,389  
Operating Expenses
Research Development11,067  9,183  15,614  8,374  
Selling General and Administrative2,013  1,588  1,270  940  
Non Recurring5  73  17   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,619) (7,386) (6,334) (6,925)
Income from Continuing Operations
Total Other Income/Expenses Net(1,805)(1,509)2,147  115  
Earnings Before Interest And Taxes(13,424)(8,895)(4,187)(6,810)
Interest Expense1,225  1,242  1,242  1,191  
Income Before Tax(14,649)(10,137)(5,429)(8,001)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(14,649)(10,137)(5,429)(8,001)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (14,649) (10,137) (5,429) (8,001)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (14,649) (10,137) (5,429) (8,001)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.